All productsKlow
Size
- 80 mg — $120.00 CAD — Available
Research focus
An MXC blend listing BPC-157, TB-500, GHK-Cu and KPV; the linked studies address individual ingredients.
In simple words
Klow is an MXC blend listing BPC-157, TB-500, GHK-Cu and KPV. The selected references examine individual ingredients, not the combined Klow vial; the listed total size does not specify each ingredient’s proportion.
Ingredient studies are shown separately. They do not demonstrate the effects, safety or synergy of the combined vial; exact sequences and unlisted proportions are not assumed. The supplied MXC menu identifies ingredients but not their individual proportions.
Research references
Reviewed 2026-10-26
Preclinical — rat tendon cells/explants
Rat Achilles tendon-derived cultures; replicate counts not stated in the reviewed abstract.
Experiments found greater tendon-explant outgrowth, cell movement and survival under oxidative stress; direct cell proliferation was not increased.
Cell/explant findings do not establish tendon healing, efficacy or safety in people.
PMID 21030672. Indexed abstract checked through Europe PMC on 2026-10-26. Selected evidence, not a systematic review.
Analytical — laboratory and horses
Equine urine/plasma and in-vitro metabolism; horse count not stated in the reviewed abstract.
The preparation tested contained N-acetylated LKKTETQ, a fragment of thymosin beta-4. Researchers developed a method to detect it and its metabolites.
This was a detection study, not a healing trial. Full-length thymosin beta-4 research cannot automatically be attributed to TB-500-labelled products.
PMID 23084823. Indexed abstract checked through Europe PMC on 2026-10-26. Selected evidence, not a systematic review.
Laboratory — fibroblast cultures
Fibroblast cultures; species and replicate count not specified in the reviewed abstract.
A glycyl-histidyl-lysine copper complex stimulated collagen synthesis in the cultured cells without increasing cell number.
A cell-culture result does not establish skin rejuvenation or wound healing in humans. Copper complexes and formulations are not interchangeable.
PMID 3169264. Indexed abstract checked through Europe PMC on 2026-10-26. Selected evidence, not a systematic review.
Preclinical — human cell lines and mice
Intestinal/immune cell lines and two induced-colitis mouse models; counts not specified in the reviewed abstract.
Researchers examined PepT1-mediated uptake of Lys-Pro-Val and found changes in inflammatory signalling and mouse-colitis measures.
Human-derived cell lines are not human clinical trials. These findings do not establish treatment of bowel disease in people.
PMID 18061177. Indexed abstract checked through Europe PMC on 2026-10-26. Selected evidence, not a systematic review.
Resources
Identity search; no unambiguous compound record assigned to this listing. Check forms and synonyms carefully.
PubChemMechanism and target search. Automated access returned 403; DrugBank was not used to substantiate claims or approval status.
DrugBankProtein/precursor search, not a record of the supplied vial. Synthetic compounds and lab supplies may have no matching protein entry.
UniProtBioactivity search. Assay results depend on the tested compound, target and experimental conditions.
ChEMBLExplore indexed literature. Search results are not supporting citations; selected verified publications appear above.
PubMedExplore registrations. A match or completed study does not establish efficacy, approval or relevance to this vial.
ClinicalTrials.govEvidence on studied compounds does not establish the identity, purity, safety, or regulatory approval of the catalogue vial. No Canadian regulatory status is assessed here.
Research questions about Klow
What is Klow?
Klow is an MXC blend listing BPC-157, TB-500, GHK-Cu and KPV. The selected references examine individual ingredients, not the combined Klow vial; the listed total size does not specify each ingredient’s proportion.
What types of research are cited for Klow?
The Klow profile contains the following selected evidence on individual ingredients. This is not a systematic review or a complete inventory of research.
BPC-157 and tendon-cell behaviour (2011): Preclinical — rat tendon cells/explants
Publication: BPC-157 and tendon-cell behaviourTB-500 identity and equine detection (2012): Analytical — laboratory and horses
Publication: TB-500 identity and equine detectionGHK-Cu and collagen synthesis (1988): Laboratory — fibroblast cultures
Publication: GHK-Cu and collagen synthesisKPV transport and inflammatory signalling (2008): Preclinical — human cell lines and mice
Publication: KPV transport and inflammatory signallingWho or what was studied in the selected Klow references?
BPC-157 and tendon-cell behaviour (2011): Rat Achilles tendon-derived cultures; replicate counts not stated in the reviewed abstract.
Publication: BPC-157 and tendon-cell behaviourTB-500 identity and equine detection (2012): Equine urine/plasma and in-vitro metabolism; horse count not stated in the reviewed abstract.
Publication: TB-500 identity and equine detectionGHK-Cu and collagen synthesis (1988): Fibroblast cultures; species and replicate count not specified in the reviewed abstract.
Publication: GHK-Cu and collagen synthesisKPV transport and inflammatory signalling (2008): Intestinal/immune cell lines and two induced-colitis mouse models; counts not specified in the reviewed abstract.
Publication: KPV transport and inflammatory signallingDo the selected studies test the exact Klow blend?
Ingredient studies are shown separately. They do not demonstrate the effects, safety or synergy of the combined vial; exact sequences and unlisted proportions are not assumed. The supplied MXC menu identifies ingredients but not their individual proportions.
What do the selected Klow studies not establish?
BPC-157 and tendon-cell behaviour (2011): Cell/explant findings do not establish tendon healing, efficacy or safety in people.
Publication: BPC-157 and tendon-cell behaviourTB-500 identity and equine detection (2012): This was a detection study, not a healing trial. Full-length thymosin beta-4 research cannot automatically be attributed to TB-500-labelled products.
Publication: TB-500 identity and equine detectionGHK-Cu and collagen synthesis (1988): A cell-culture result does not establish skin rejuvenation or wound healing in humans. Copper complexes and formulations are not interchangeable.
Publication: GHK-Cu and collagen synthesisKPV transport and inflammatory signalling (2008): Human-derived cell lines are not human clinical trials. These findings do not establish treatment of bowel disease in people.
Publication: KPV transport and inflammatory signallingThese studies do not establish the identity, purity, safety or effects of the MXC Klow vial. Findings in one formulation, population or experimental model should not be assumed to apply to another.